Literature DB >> 10638998

Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins.

V Bataille, H Snieder, A MacGregor, T Spector.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10638998      PMCID： PMC2363190          DOI： 10.1054/bjoc.1999.0908

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  11 in total

1.  Human homolog of patched, a candidate gene for the basal cell nevus syndrome.

Authors:  R L Johnson; A L Rothman; J Xie; L V Goodrich; J W Bare; J M Bonifas; A G Quinn; R M Myers; D R Cox; E H Epstein; M P Scott
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

Review 2.  Renal cell carcinoma and interleukin-2: a review.

Authors:  J Wagstaff; J W Baars; G J Wolbink; K Hoekman; A J Eerenberg-Belmer; C E Hack
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

3.  Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma. A randomized trial.

Authors:  G Steineck; H Strander; B E Carbin; E Borgström; L Wallin; U Achtnich; A Arvidsson; V Söderlund; I Näslund; P L Esposti
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

4.  The power of the classical twin study to resolve variation in threshold traits.

Authors:  M C Neale; L J Eaves; K S Kendler
Journal:  Behav Genet       Date:  1994-05       Impact factor: 2.805

Review 5.  Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome.

Authors:  V E Kimonis; A M Goldstein; B Pastakia; M L Yang; R Kase; J J DiGiovanna; A E Bale; S J Bale
Journal:  Am J Med Genet       Date:  1997-03-31

6.  Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9.

Authors:  M R Gailani; S J Bale; D J Leffell; J J DiGiovanna; G L Peck; S Poliak; M A Drum; B Pastakia; O W McBride; R Kase
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

7.  Multiinstitutional home-therapy trial of recombinant human interleukin-2 and interferon alfa-2 in progressive metastatic renal cell carcinoma.

Authors:  J Atzpodien; E Lopez Hänninen; H Kirchner; H Bodenstein; M Pfreundschuh; U Rebmann; B Metzner; H J Illiger; G Jakse; T Niesel
Journal:  J Clin Oncol       Date:  1995-02       Impact factor: 44.544

8.  Hereditary factors in basal cell carcinoma of the skin: a population-based cohort study in twins.

Authors:  T Milán; J Kaprio; P K Verkasalo; C T Jansén; L Teppo; M Koskenvuo
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

9.  Patients with metastatic renal carcinoma candidate for immunotherapy with cytokines. Analysis of a single institution study on 181 patients.

Authors:  T Philip; S Negrier; C Lasset; B Coronel; M Bret; J Y Blay; Y Merrouche; C Carrie; P Kaemmerlen; F Chauvin
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

10.  Subcutaneous administration of interleukin 2 and interferon-alpha-2b in advanced renal cell carcinoma: a confirmatory study.

Authors:  G Facendola; M C Locatelli; G Pizzocaro; L Piva; C Pegoraro; E B Pallavicini; A Signaroldi; M Meregalli; F Lombardi; G D Beretta
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.